[Skip to Content]
[Skip to Content Landing]

Year

Day

November 6, 2019
Original Investigation

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial

Abstract Full Text
open access
JAMA Dermatol. Published online November 6, 2019. doi:https://doi.org/10.1001/jamadermatol.2019.3336

This phase 3 randomized clinical trial evaluates the efficacy and safety of 2 dose regimens of dupilumab for treatment of moderate to severe atopic dermatitis in adolescents.

JAMA Dermatology Clinicopathological Challenge

Asymptomatic Infiltrated Erythematous Skin Patch on the Breast

Abstract Full Text
has active quiz
JAMA Dermatol. Published online November 6, 2019. doi:https://doi.org/10.1001/jamadermatol.2019.3273

A woman in her early 80s presented with a 6-month history of an asymptomatic, enlarging, partly infiltrated erythematous cutaneous patch localized to the periareolar area of her left breast. What is your diagnosis?

Research Letter

Prevalence of Pemphigoid as a Potentially Unrecognized Cause of Pruritus in Nursing Home Residents

Abstract Full Text
JAMA Dermatol. Published online November 6, 2019. doi:https://doi.org/10.1001/jamadermatol.2019.3308

This cross-sectional study of 125 residents of 7 nursing homes in the Netherlands evaluates the prevalence of pemphigoid as a potentially unrecognized cause of pruritus.

Observation

Capecitabine-Related Eruption Mimicking Dermatomyositis in 2 Patients With Metastatic Breast Cancer

Abstract Full Text
JAMA Dermatol. Published online November 6, 2019. doi:https://doi.org/10.1001/jamadermatol.2019.3162

This case report describes the occurrence of capecitabine-related eruption in 2 patients with metastatic breast cancer.

×